Merck posts bigger quarterly loss

Pharmaceutical firm said net loss widened year on year to $872m in the fourth quarter

Dubai seeks to attract $2.5 billion in investments to the pharmaceutical industry in the next five years. AFP

Reuters

US drugmaker Merck & Co reported a bigger quarterly loss on Friday, partly due to a $2.6 billion charge related to recent changes to the US tax law.

Merck's net loss attributable widened to $872 million, or 32 cents per share, in the fourth quarter, from $594m, or 22 cents per share, a year earlier.

______________

Read more:

[ New cyber attacks spread across Europe to the US ]

[ Dubai seeks to attract $2.5bn to pharmaceutical sector as part of 2030 industrial strategy ]

_______________

The company said its research and development expenses fell 56 per cent to $2.06bn in the quarter.

Updated: February 02, 2018, 1:49 PM